Systematic Review of , , , , , and Gene Polymorphisms and Meta-Analysis of Variant and Its Association with Overweight and Obesity Risk in Men

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2025 Jan 8

PMID 39769263

Authors

Aleksandra Bojarczuk

Aleksandra Garbacz

Cezary Zekanowski

Beata Borzemska

Pawel Cieszczyk

Ewelina Maculewicz

Affiliations

Soon will be listed here.

Abstract

Obesity is a complex health risk influenced by genetic, environmental, and lifestyle factors. This review systematically assessed the association between interleukin gene polymorphisms (rs16944, rs17561, rs1143623, rs1143633, rs1143634, rs1800587, rs2234677, and rs4848306), (rs180275, rs1805010, rs13306435, rs1800795, rs1800796, rs1800797, rs2228145, rs2228145, rs2229238, and rs4845623), (rs1518110, rs1518111, rs1800871, rs1800872, rs1800896, rs1878672, rs2834167, rs3024491, rs3024496, rs3024498, and rs3024505), (rs3136617, rs3136618, and rs2296135), and (rs187238, rs1946518, rs2272127, rs2293225, and rs7559479) and the risk of overweight and obesity in adults, focusing on rs1800795 through a meta-analysis. The focus on in this review arises from its pleiotropic nature and unclear effect on obesity risk. The review included studies published from 1998 to 2023, sourced from Science Direct, EBSCOhost, Web of Science, and Google Scholar. Bias was assessed with the Cochrane Collaboration tool, and funnel plots were used for publication bias. Results were synthesized into pooled odds ratios (ORs) and confidence intervals (CIs). Thirty studies comprising approximately 29,998 participants were included. The selection criteria required that the articles include participants who were overweight or obese, and this condition needed to be linked to polymorphisms. In a meta-analysis, in the dominant model, the pooled OR was 1.26 (95% CI 1.08 to 1.47), indicating those with the GC/CC genotype for rs1800795 are 1.26 times more likely to be overweight/obese than GG genotype carriers. For the recessive model, the OR was 1.25 (95% CI 1.04 to 1.51). The overdominant model showed no significant association (OR 1.08, 95% CI 0.94 to 1.25). Interleukin gene variation, particularly the rs1800795 variant, is modestly associated with obesity risk. This suggests that other factors, such as the environment, also play a role in obesity. Thus, individuals with this particular variant may have a slightly higher likelihood of being overweight or obese compared to those without it, but this is just one of many factors influencing obesity risk.

References

Furmanczyk P, Quinn L . Interleukin-15 increases myosin accretion in human skeletal myogenic cultures. Cell Biol Int. 2003; 27(10):845-51. DOI: 10.1016/s1065-6995(03)00172-0. View

Sindhu S, Thomas R, Shihab P, Sriraman D, Behbehani K, Ahmad R . Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PLoS One. 2015; 10(7):e0133494. PMC: 4511728. DOI: 10.1371/journal.pone.0133494. View

De Lorenzo A, Martinoli R, Vaia F, Di Renzo L . Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis. 2006; 16(8):513-23. DOI: 10.1016/j.numecd.2005.10.010. View

Bouchard C . Genetics of Obesity: What We Have Learned Over Decades of Research. Obesity (Silver Spring). 2021; 29(5):802-820. DOI: 10.1002/oby.23116. View

Matsuki T, Horai R, Sudo K, Iwakura Y . IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med. 2003; 198(6):877-88. PMC: 2194201. DOI: 10.1084/jem.20030299. View

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

Coppack S . Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001; 60(3):349-56. DOI: 10.1079/pns2001110. View

Oana M, Claudia B, Carmen D, Maria P, Septimiu V, Claudiu M . The role of IL-6 572 C/G, 190 C/T, and 174 G/C gene polymorphisms in children's obesity. Eur J Pediatr. 2014; 173(10):1285-96. DOI: 10.1007/s00431-014-2315-5. View

Maculewicz E, Mastalerz A, Antkowiak B, Antkowiak O, Garbacz A, Szarska E . The effect of gene polymorphism on obesity parameters in highly physically active young men. Biol Sport. 2022; 39(4):1117-1125. PMC: 9536378. DOI: 10.5114/biolsport.2023.118336. View

10.

Adler G, Skonieczna-Zydecka K, Madlani A, Ogonowski J, Grochans E, Pierzak-Sominka J . Association between depression, parameters of adiposity and genetic polymorphisms of pro-inflammatory cytokines: IL-1α, IL-1β, IL-2 and IL-6 in subjects over 55 years old. Acta Biochim Pol. 2016; 63(2):253-9. DOI: 10.18388/abp.2015_1063. View

11.

Gupta A, Gupta V, Singh A, Tiwari S, Agrawal S, Natu S . Interleukin-6 G-174C gene polymorphism and serum resistin levels in North Indian women: potential risk of metabolic syndrome. Hum Exp Toxicol. 2010; 30(10):1445-53. DOI: 10.1177/0960327110393763. View

12.

Berthier M, Paradis A, Tchernof A, Bergeron J, Prudhomme D, Despres J . The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet. 2003; 48(1):14-9. DOI: 10.1007/s100380300002. View

13.

Fletcher J . What is heterogeneity and is it important?. BMJ. 2007; 334(7584):94-6. PMC: 1767262. DOI: 10.1136/bmj.39057.406644.68. View

14.

Klipstein-Grobusch K, Mohlig M, Spranger J, Hoffmann K, Rodrigues F, Sharma A . Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study. Obesity (Silver Spring). 2006; 14(1):14-8. DOI: 10.1038/oby.2006.3. View

15.

Song Y, Miyaki K, Araki J, Zhang L, Omae K, Muramatsu M . The interaction between the interleukin 6 receptor gene genotype and dietary energy intake on abdominal obesity in Japanese men. Metabolism. 2007; 56(7):925-30. DOI: 10.1016/j.metabol.2007.02.006. View

16.

Di Renzo L, Del Gobbo V, Bigioni M, Premrov M, Cianci R, De Lorenzo A . Body composition analyses in normal weight obese women. Eur Rev Med Pharmacol Sci. 2006; 10(4):191-6. View

17.

Garcia M, Wernstedt I, Berndtsson A, Enge M, Bell M, Hultgren O . Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes. 2006; 55(5):1205-13. DOI: 10.2337/db05-1304. View

18.

Ghanemi A, St-Amand J . Interleukin-6 as a "metabolic hormone". Cytokine. 2018; 112:132-136. DOI: 10.1016/j.cyto.2018.06.034. View

19.

Elbe-Burger A, Egyed A, Olt S, Klubal R, Mann U, Rappersberger K . Overexpression of IL-4 alters the homeostasis in the skin. J Invest Dermatol. 2002; 118(5):767-78. DOI: 10.1046/j.1523-1747.2002.01753.x. View

20.

Bruun J, Verdich C, Toubro S, Astrup A, Richelsen B . Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol. 2003; 148(5):535-42. DOI: 10.1530/eje.0.1480535. View